CompoAtlas

Bioavailable Boswellia Phytosome

Natural health product licensed in Canada

Licence holder
Accurex Health Care Manufacturing Inc.
NPN or DIN-HM
80092675
Status
Active licence
Licence date
5 June 2019
Revision date
26 June 2019
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Indian Frankincense Boswellic acids-Phosphatidylcholine complex

Source : Résine de gomme

Potency : 62.5 mg Boswellic acids

183.75 mgNot calculated
Indian Frankincense Boswellic acids-Phosphatidylcholine complex

Source : Helianthus annuus (sunflower seed)

Potency : 62.5 mg Boswellic acids

183.75 mgNot calculated

Non-medicinal ingredients

Hypromellose, Cellulose microcristalline, Stéarate de magnésium, Silicon dioxide colloïdal

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Vcapsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve symptoms associated with knee pain. Helps to relieve abdominal pain and cramping associated with Irritable Bowel Syndrome (IBS).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80092675

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line